CFTR MODULATOR THERAPY FOR CYSTIC FIBROSIS CAUSED BY THE RARE C.3700A>G MUTATION

被引：0

作者：

Phuan, P. ^{[1
]}

Haggie, P. M. ^{[1
]}

Tan, J. T. ^{[1
]}

Rivera, A. ^{[1
]}

Finkbeiner, W. ^{[1
]}

Nielson, D. W. ^{[1
]}

Thomas, M. ^{[2
]}

Janahi, I. A. ^{[3
]}

Verkman, A. S. ^{[1
]}

机构：

[1] UC San Francisco, Dept Med, San Francisco, CA USA

[2] Hamad Med Corp, Dept Chest, Doha, Ad Dawhah, Qatar

[3] Sidra Med & Res Ctr, Pediat Med, Doha, Ad Dawhah, Qatar

来源：

PEDIATRIC PULMONOLOGY | 2020年 / 55卷

关键词：

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

440

引用

页码：S210 / S210

页数：1

共 50 条

[21] Improving outcomes of infections in cystic fibrosis in the era of CFTR modulator therapy
Saiman, Lisa
PEDIATRIC PULMONOLOGY, 2019, 54 : S18 - S26
[22] Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy
Yi, Buqing
Dalpke, Alexander H.
Boutin, Sebastien
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
[23] Effect of CFTR modulator therapy on cystic fibrosis-related diabetes
Gaines, Holly
Jones, Kellie R.
Lim, Jonea
Medhi, Nighat F.
Chen, Sixia
Scofield, R. Hal
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (06)
[24] Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy
Tewkesbury, Daniel H.
Robey, Rebecca C.
Barry, Peter J.
BREATHE, 2021, 17 (04)
[25] ADVANCING CFTR MODULATOR THERAPY FOR THE VAST MAJORITY OF PATIENTS WITH CYSTIC FIBROSIS
Rowe, S. M.
Taylor-Cousar, J. L.
PEDIATRIC PULMONOLOGY, 2019, 54 : S108 - S109
[26] Impact of CFTR modulator therapy in the Cystic Fibrosis microbiome - a retrospective study
Balanco, Leticia Pavao
Cortesao, Chantal
Cemlyn-Jones, Jessica
Gamboa, Fernanda
EUROPEAN RESPIRATORY JOURNAL, 2024, 64
[27] CHARACTERIZATION OF SLEEP IN EMERGING ADULTS WITH CYSTIC FIBROSIS ON CFTR MODULATOR THERAPY
Meltzer, Lisa
Jump, Stephanie
Gross, Jane
SLEEP, 2022, 45 : A267 - A267
[28] Kidney effects of triple CFTR modulator therapy in people with cystic fibrosis
Gabai, Pierre
Novel-Catin, Etienne
Reynaud, Quitterie
Nove-Josserand, Raphaele
Pelletier, Solenne
Fouque, Denis
Koppe, Laetitia
Durieu, Isabelle
CLINICAL KIDNEY JOURNAL, 2024, 17 (10)
[29] Diagnosis of cystic fibrosis in adulthood and eligibility for novel CFTR modulator therapy
Farley, Hannah
Poole, Sarah
Chapman, Stephen
Flight, William
POSTGRADUATE MEDICAL JOURNAL, 2022, 98 (1159) : 341 - 345
[30] Clinical efficacy of CFTR modulator therapy in people with cystic fibrosis carrying the I1234V mutation
Aluma, Bat El Bar
Reiter, Joel
Efrati, Ori
Bezalel, Yael
Keler, Shlomit
Ashkenazi, Moshe
Dagan, Adi
Buchnik, Yael
Sadras, Ido
Cohen-Cymberknoh, Malena
JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (04) : 685 - 689

← 1 2 3 4 5 →

CFTR MODULATOR THERAPY FOR CYSTIC FIBROSIS CAUSED BY THE RARE C.3700A&gt;G MUTATION

CFTR MODULATOR THERAPY FOR CYSTIC FIBROSIS CAUSED BY THE RARE C.3700A>G MUTATION